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Abstract
Background: The SMS text Adherence suppoRt for people with type 2 diabetes (StAR2D) intervention is a
pragmatic randomised controlled trial, testing the effectiveness of brief text messaging for improving clinical
outcomes and medication adherence. The intervention did not impact glycaemic control. We conducted a pre-and
post-trial process evaluation alongside the StAR2D study in Malawi and South Africa, exploring the experiences and
perceptions of patient participants, to better understand potential underlying reasons for the trial outcomes.
Methods: We employed a qualitative research design, including conducting semi structured in-depth interviews
and focus groups at both trial sites. Purposive sampling was used to ensure representation of a wide range of
patients with type 2 diabetes with regards to age, gender, ethnicity, language, and duration of diabetes. We
interviewed the same participants at baseline and at the end of the trial. We used within-case and across-case
thematic analysis to identify key themes.
Results: Brief messages delivered by text were acceptable and useful for addressing informational and support
needs for participants. Some participants reported behaviour changes because of the text reminders and advice on
a healthy lifestyle. Both participating in the trial and the messages were experienced as a source of support, caring,
and motivation. Participants’ ability to act on the messages was limited. A common theme was frustration over the
lack of ability to effectively control one’s blood glucose level. They reported a range of routinised, partial diabetes
care adherence behaviours, shaped by complex and interacting individual, social, and health service factors.
Participant responses and intervention impact were similar across sites, despite differences in health services.
Conclusion: This process evaluation provided context and insight into the factors influencing participants’
engagement with the text messaging intervention. The complex context in which patients take their diabetes
medication, may explain in part, why brief text messaging may have been insufficient to bring about changes in
health outcomes. The scale of need for self-management and health service support, suggests that health system
strengthening, and other forms of self-management support should accompany digital communication
interventions. (Current Controlled Trials ISRCTN70768808, registered 03/08/2015.)
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Background
Introduction
Type 2 diabetes mellitus (T2DM) is a major global pub-
lic health concern [1]. Low- and middle-income coun-
tries (LMICs) are disproportionally affected by a large
and growing burden of premature morbidity and mortal-
ity associated with chronically elevated blood glucose
levels [1, 2], with an estimated 75% of people with dia-
betes living in LMICs [3]. In sub-Saharan Africa, it was
estimated that 12.1 million people were living with dia-
betes in 2010, and numbers are projected to increase to
23.9 million by 2030 [4]. T2DM is the most common
form accounting for over 90% of cases [5]. Health out-
comes for people treated for T2DM could be substan-
tially improved in sub-Saharan Africa, but failure to take
diabetes medicine regularly and to follow a healthy life-
style (described as non-adherence), can result in failure
to achieve the benefits of effective medical treatment
and improved health outcomes [6, 7]. Medication non-
adherence is common, estimated at 30–50% of people
with long-term conditions, across diverse diseases and
patient groups [8]. In sub-Saharan Africa, glucose levels
are adequately controlled in less than a third (27%) of
the diabetic patients, and 60% or more have complica-
tions [5, 9]. Reasons for not collecting or taking medica-
tions as intended are well documented and include
psychological factors, lack of social support, low levels of
health literacy, and health care service interactions that
do not effectively support self-management [10–15].
Diabetes prevalence and associated morbidity, mortality,
and health expenditure are placing a major social, finan-
cial and health service burden on the world [16], which
is worsened in overburdened and low resource settings,
such as sub-Saharan Africa.
Targeted digital client communication, using mobile
phone-based, brief text messaging (also referred to as
short message service or SMS), has been recommended
for adherence support for a range of health issues and
for smoking cessation and adherence to anti-retroviral
treatment [17, 18]. Brief text messaging has also shown
promise for supporting adherence for diabetes [19–24].
However, there are limits to the utility of the evidence
for implementing digital brief messaging at scale, as re-
sults are often mixed or uncertain [17, 20, 21, 25–28], or
come from smaller scale studies, and stakeholder views
are not always explored [20, 21, 29–32]. Even where evi-
dence from experimental studies (such as randomised
controlled trials) are available, it is difficult to
understand the underlying reasons for the effect (or lack
thereof), as such studies do not illuminate the under-
lying pathways of behaviour change [21, 31]. Process
evaluations alongside these studies, can generate insights
into the potential underlying influences and causal path-
ways, and enhance the utility, and applicability of the
evidence [12, 31, 33–36].
We conducted a pre-and post-trial process evaluation
alongside a randomised controlled trial that tested the
effectiveness of brief text messaging in improving health
outcomes and medication adherence compared to usual
care in patients with T2DM in two LMICs, Malawi
(MLW) and South Africa (SA). The aim of the process
evaluation was to explore the experiences and percep-
tions of patient participants, to help understand the po-
tential underlying reasons for the trial outcomes.
Understanding patient participants’ expectations, beliefs,
responses, and satisfaction with the intervention is also
important for assessing the acceptability and feasibility
of the intervention for future upscaling [12, 31, 33, 34,
37].
The trial study
SMS text Adherence suppoRt for people with type 2 dia-
betes (StAR2D) intervention is a pragmatic randomised
controlled trial in two sub-Sharan settings, Malawi, and
South Africa (Current Controlled Trials ISRC
TN70768808, registered 03/08/2015). The trial tested
the effectiveness of sending brief, automated SMS text-
messages, using the patient’s own mobile phone, for im-
proving clinical outcomes and adherence to refilling
medicine, in patients with T2DM, compared to controls.
The trial evaluated a range of clinical and behavioural
outcomes. The primary trial outcome was glucose con-
trol (HbA1c), secondary clinical outcomes included con-
trol of blood pressure (systolic blood pressure) and
measures of the proportions of the participants reaching
treatment goals (with blood glucose, HbA1c < 8% and
systolic blood pressure < 140 mmHg.) The main behav-
ioural outcome was an objective measure of adherence;
the proportion of days covered for prescribed
medications.
Mobile messaging involved receiving up to four SMS
text-messages each week, for 12 months, promoting
regular medication refill, medication, and healthy life-
style changes. Messages were delivered via a remote ser-
ver, in one of four local languages (English, Chichewa,
isiXhosa, and Afrikaans). Messages were one-directional
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and semi-tailored to reflect the clinic setting. Partici-
pants could choose their preferred language and timing
of message delivery. Controls had usual care and re-
ceived infrequent, trial-related messages (no more than
1 per month), that were sent to all participants. Forma-
tive research (that included input from patient and staff
stakeholders) contributed an evidence and theory-
informed set of brief text-messages and delivery mecha-
nisms, as documented elsewhere [38]. The trial protocol
provide further details of the study design and interven-
tion mechanisms [39].
The trial was completed in October 2018, and publica-
tion of the results are in submission (see preliminary re-
sults in the ISRCTN Registry) [40]. To summarise, trial
results did not provide convincing evidence that well-
designed text messages lead to changes in glycemic con-
trol for people with T2DM at 12months, though there
was evidence of clinically important impact on blood
pressure and overall cardiovascular risk. Findings were
similar between trial sites (paper in submission). The
process evaluation findings presented here offer some
insights about the possible underlying reasons for the




The process evaluation study was conducted alongside
the main trial at the same local healthcare facilities in
Lilongwe, Malawi and Cape Town, South Africa. Both
sites serve low-income communities and have a high
burden of T2DM. The estimated prevalence of diabetes
in Malawi, for 2014, was 6.6% for men and 6% for
women. For South Africa, the estimated prevalence was
higher for men at 9.7 and 12.6% for women [41]. Dia-
betes care is provided free of charge at both sites, includ-
ing essential medicines and laboratory tests at no cost to
patients.
In Lilongwe, patients with diabetes have scheduled ap-
pointments every 3 months for a health check and to re-
fill their medications. In Cape Town, the medical check-
ups are bi-annual, and the medication refills are once a
month or every 2 months. The Lilongwe health facility
serves patients from the city as well as those living in
the surrounding areas (up to 2 h by public transport),
whereas in Cape Town, most patients live within a short
distance away (the furthest being a 30-min walk away).
Study design
We carried out a process evaluation using qualitative re-
search methods, in a phenomenological approach that
aimed to examine the lived experiences of humans,
through systematic collection and analysis of narrative
material [42]. We collected data at both sites using semi
structured in-depth interviews (IDIs) and focus groups
discussions (FGDs) with purposive and convenience
sampling of stakeholders. Combining IDIs and FGDs fa-
cilitate a deeper comparison of perspectives, improve
data completeness and enhance the trustworthiness of
findings [43]. While interviews enable one to explore in-
dividual views and experiences in detail, the conversa-
tional nature and interaction in a focus group can help
generate additional insights, test and refine understand-
ings from individual interviews, and stimulate commen-
tary that may not have been elicited from individual
interviews [44].
Participants recruited were men and women, 18 and
older, clinically diagnosed with T2DM and taking dia-
betes treatment (oral medication or both oral and insu-
lin). Purposive sampling was used to ensure
representation of the wide range of patients with T2DM
in the study areas, with regards to age, gender, ethnicity,
language, and duration of diabetes. For the pre-trial in-
terviews, we selected participants that met our criteria,
from an anonymized list of participants that had been
recruited for the trial. A research assistant, with the help
of the trial staff, invited recruits to participate in a pre-
trial individual interview, in person in waiting rooms or
via telephone Pre-trial interviews were conducted after
enrolment into the trial and before the participant was
randomised. We interviewed the same participants at
the end of the trial. We did not monitor the number of
participants who declined to participate. Participants
were reimbursed for their travel and time following local
country research guidelines.
We conducted individual interviews with participants
allocated to the intervention group, as well as those in
the control group receiving usual care (See Table 1 for
breakdown). Control group participant messaging were
infrequent, mainly trial related messages. We wanted to
better understand both intervention and control partici-
pations’ experiences, to see if and how their trial partici-
pation may have contributed to their responses. In a
similar study on adherence to hypertension treatment,
we found that control participants also valued their par-
ticipation in the trial [12].
The process evaluation builds on the StAR2D forma-
tive work that was conducted to develop a evidence- and
theory-informed brief text message intervention [45],
using the Capability, Opportunity, Motivation - Behav-
iour (COM-B) behaviour change framework. The COM-
B framework consolidates evidence from several other
behaviour change theories and developed a behaviour
change taxonomy that can account for contextual factors
influencing behaviour (like socio-economic conditions
and health service factors) [46–48]. It has been widely
used for studying behaviour change, including for pro-
moting adherence behaviour [48–50]. The framework
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details three main dimensions that drives behaviour
change; Capability, Opportunity, and Motivation, each
with a subset of behaviour change strategies. COM-B
states that an individual needs adequate capability, op-
portunity, and motivation for a behaviour to take place
(such as taking medicine), and that a deficit in any of
these three areas means the behaviour is unlikely to
occur. An individual’s capability to adhere to medicine
and treatment may be affected by psychological factors
of knowledge and memory; opportunity for adherence
may be affected by access to medicine and support, as
well as by physical and social barriers, and motivation
may be affected by psychological factors such a self-
confidence, values, and beliefs [48]. The COM-B frame-
work provided theoretical guidance for developing the
brief-text messages for the StAR2D intervention; the
messages aimed to encapsulate key behaviour change
strategies within the three domains (capability, oppor-
tunity, motivation) of the framework [38]. In this process
evaluation, we continued our use of the COM-B frame-
work, to assist our analysis of underlying reasons for
participant responses [48].
Data collection and analysis
Interviews and focus groups were conducted in private
spaces, either at the health facility, or at the research
agency (Lilongwe), or a nearby community center (Cape
Town). For pre-trial interviews, using a semi-structured
topic guide, the researcher explored experiences and
perceptions of diabetes, sources of information and sup-
port, challenges, and opportunities in managing diabetes,
experiences of receiving healthcare, access to mobile
phones, attitudes to receiving health messaging via their
mobile phones, as well as understanding and expecta-
tions of participation in the study (See Additional file 1
for the pre-trial interview guide). We analysed, but do
not report separately on the pre-trial interviews. Pre-trial
interview data helped with tracking the patient journey
over time, and provide contextual information to better
their responses to the intervention. In the post-trial in-
terviews and focus groups, we focused on participants’
experience and perception of the brief messaging inter-
vention, changes in adherence behaviour and health sta-
tus over time, and whether text messaging may have
influenced behaviour. (See Additional file 2 for the post-
trial interview guide).
End of trial interviews happened once the participants
had completed the trial and at this stage the qualitative
researchers were given confidential access to the alloca-
tion status of participants. Training took place to avoid
unblinding trial staff to individual allocation status. Data
was captured with digital voice recording and was tran-
scribed with anonymization. In Malawi, data collection
was conducted in Chichewa, and translated into English
during the transcription process by trained researchers
(HN, CM, MN). In Cape Town, an English-speaking re-
searcher (SC) conducted pre-trial data collection (most
participants are bilingual), with the help of a Xhosa-
speaking translator for the focus groups. In Cape Town,
the post-trial interviews and focus groups were con-
ducted by a researcher (NS), who is bilingual (isiXhosa
and English). Interviewers were female, trained, graduate
and post-graduate social scientists. Individual interviews
lasted 45–90 min and focus groups lasted 90–120min.
Interview summaries, capturing the key issues and re-
searcher reflections, were completed within 36 h of con-
ducting the interview, and was used for initial and
iterative analysis of the data. The in-country lead re-
searchers did this initial analysis together with the inter-
viewer. Final analysis, based on interview summaries and
transcripts was done by the first author (NL1). We used
a combination of inductive and deductive analysis, using
a coding framework informed by the categories explored
in the interview schedule and by iterative analysis of
interview summaries. We analysed the data along two
dimensions. The primary dimension was an across-case
Table 1 Data sources and demographics of participants
Data sources Lilongwe Cape Town
IDIs (Intervention group)
Matched pairs,
n = 14 (28 IDIs)
Post-trial only, n = 2 IDIs
Total = 8
4 Female participants
Total = 8 (6 matched, 2 post-trial only)
5 Female participants
4 Male participants 3 Male participants
IDIs (Control group)




5 Male participants 2 Male participants
FGDs (Intervention group)
Post-trial FGD, n = 4
(25 participants)
Total = 2 (12 participants)
1 Female FGD, 6 participants
Total = 2 (13 participants)
1 Female FGD, 6 participants
1 Male FGD, 6 participants 1 Male FGD, 7 participants
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analysis, where we compared and contrasted views
across individual post-trial interviews, and between
intervention and control group participants. A secondary
dimension was analyzing individual pre-and post-trial in-
terviews as pairs, for a longitudinal view of participant’s
experiences and views. For the latter, we only report on
notable changes from baseline interviews and contextual
information for understanding an individual’s post-trial
responses. Themes identified in FGDs supplemented the
data from the interviews and allowed for data triangula-
tion. Standard approaches to ensuring the quality of the
methodology were used, including the use of a coding
framework, confirmation of accuracy of initial analysis
by the interviewers, reaching data saturation and report-
ing of divergent views.
Details of data sources and gender of participants are
shown in Table 1 in the results section. In sum, a total
of 28 individuals participated in individual interviews,
with 26 of those being repeat interviews (pre-and post-
trial with the same individuals) and 2 being only post-
trial interviews (54 individual interviews in total).
Twenty-five individuals participated in the 4 post-trial
focus groups we conducted (2 each per country). The
gender distribution was close to even for both the inter-
views and focus groups, with 26 females and 28 males
participating overall. The age range of participants was
38 to 72 years and the duration of them living with dia-
betes (by the end of the trial), ranged from 18months to
11 years. The level of co-morbidity was high, with most
participants receiving treatment for at least one other
condition, the most common being high blood pressure
(others were high cholesterol, heart problems, asthma,
HIV, anxiety, and depression).
Ethical approval
Ethical approval to conduct the study was obtained from
the University of Cape Town (126/2015), National
Health Sciences Research Committee of Malawi (15/7/
1425) and Oxford Tropical Research Ethics Committee
(22–15). All participants who were included in the study
provided written, informed consent to participate.
Results
Demographics
Details of data sources and gender of participants are
shown in Table 1 and summarised in the Methods sec-
tion. The table details the allocation status (intervention
or control group in the trial) of participants in this quali-
tative study. A total of 16 individuals interviewed had
been in the trial intervention group, while all 25 partici-
pants in the focus groups had been in the intervention
group.
General experience of the brief text message intervention
Expectations, acceptability, and varying engagement with
brief messages
At the start of the trial, participants appeared to have a
clear understanding of and reasonable expectations re-
garding their participation in trial. They hoped to learn
more about diabetes and welcomed the idea of receiving
messages to support their adherence to diabetes
treatment.
At the end of the trial, participants were positive about
the intervention, finding it acceptable, and useful. Sev-
eral reported an improvement in their health, in terms
of lowered and stabilized blood sugar levels (from high
levels they had reported at the start of the trial). How-
ever, participants’ level of engagement with the brief
messages and their responses to the messages varied.
Some reported that the messages helped with the im-
provement in their health and adherence behaviour,
while others felt they had no real need for it (though it
could benefit others). A participant recalled different
messages he found useful:
“Yes, the ones they normally send you says: ‘Have
you drunk your medication today?’, or ‘It’s close to
your appointment’, ‘Remember to stay hydrated’,
‘Stay away from sugary foods.’” (Male, SA, FGD)
Those who reported an improvement in their health
felt this was due mainly to their increased confidence in
managing their disease, helped by a greater acceptance
of the disease and by family support. For some, it was
the reminder messages that helped them to refill and
take their medications more regularly. Healthy lifestyle
messages were valued as reminders of the importance of
diet, exercise, and stress management, and for its prac-
tical advice. More generally, the messages provided in-
creased confidence and self-responsibility for taking
their medications. A few participants expressed disap-
pointment that the messages merely reinforced what
they knew already, and a few would have preferred two-
way communication that allowed for direct consultation
with health staff.
Relational elements of the brief text messaging intervention
Participants identified messages and how this influenced
their adherence behaviour, but they also identified more
subtle relational effects that related to their participation
in the trial. There are two elements to the relational ef-
fect. The first is that participants had appreciation for
the content of the messages, as well as for the experience
of receiving the brief messages. Messages generated a
sense of encouragement and support, and it felt as if
they had a supportive relationship with the sender of the
messages. Message content was useful, but receiving a
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message also felt like an act of caring. One participant
described it this way:
“I feel like there is someone out there who cares
about me, who thinks about me. He sends me a mes-
sage to tell me to take my medication. It's nice to
have someone who sends messages.” (Male, SA,
FGD)
A participant, who had been living with diabetes for 4
years, expressed a similar sentiment about feeling cared
for, as if someone sent her a prayer:
“You know, it not about the message. You send a
message to my phone; I take it as a prayer … know-
ing there is somebody that cares.” (Female, SA, IDI)
A second element is that some participants, in both
the intervention and control groups, felt encouraged and
supported by merely participating in the trial study, irre-
spective of receiving regular messages. Participants
showed appreciation for the positive interactions they
had had with research staff during the study enrollment
and exit procedures. They recalled feeling respected and
listened to, could ask questions, and learn more about
their condition, without feeling judged. One participant
said she had a similar feeling of being listened to when
she saw a psychiatrist for anxiety, while another felt she
had a companion, whom she could “talk to in my head”.
Some in the control group had similar feelings of being
cared for, especially when receiving a ‘Happy Birthday’
message.
Experience and responses to brief text messages in
relation to health
Reminder messages as prompts for refilling medicine
Participants in both sites knew the importance of refill-
ing their medication and reported that most of the time,
they remembered their appointment dates, and could
collect their medicines on schedule. Participants contin-
ued using the same reminder strategies they reported at
the start of study, such as checking their appointment
dates intermittently, and relying on family to remind
them. The reminder messages helped some participants
play a more active role in developing strategies to re-
member, and to be less reliant on family. For instance,
checking their due date in their patient-held record
(called Health passport in Malawi) or their clinic ap-
pointment card (South Africa). Several participants ac-
knowledged that they sometimes struggled to remember
their medicine pick-up date (due to being forgetful, or a
busy lifestyle), and some found the reminder messages
particularly helpful.
“I told you that I easily forget things, but the mes-
sages were reminding me, especially the clinic day, I
tend to forget it, but the messages were reminding
me.” (Female, MLW, FGD)
The reminders were useful for the extra prompt it pro-
vided, even for those who considered themselves to be
strict about their adherence, as expressed by one
participant:
“The SMS you guys sent us is very great. It helps be-
cause it encourages you to stay on this programme,
and without this programme, you know, we are hu-
man, you will find ways of dodging the issue, pre-
venting yourself from going to the doctor.” (Male, SA,
FGD)
Participants also spoke of a range of obstacles that
sometimes prevented them from refilling their medica-
tion. In Malawi, these included economic factors, such
as having no money for transport for their 3-monthly
visits (some travelled for a 2-h journey by public trans-
port) and having no money to purchase their medication
privately when the clinic was out of stock. In South Af-
rica, refilling required more frequent visits (monthly or 2
monthly). Due to clinic constraints, this usually required
getting in line in the early morning hours before the
clinic door opened, followed by long waiting times inside
the clinic, clinic congestion and poor interactions with
staff, experiences which made them reluctant to visit the
clinic on their appointed dates.
Reminders to prompt and motivate taking medicine as
prescribed
Participants indicated that for the most part, they take
their medicine as prescribed, though several acknowl-
edged it was an ongoing struggle. They continued to use
the same reminder strategies as before the study, such as
visual cues and daily routine, placing the medication on
the bedside or kitchen table so its visible in morning,
evening, and mealtimes. They also depended on family
to remind them.
A few reported being strict about sticking to their
medicine regimen (especially if also taking insulin) and
having a sense of pride about being adherent to treat-
ment. Some acknowledged not always taking their medi-
cation as prescribed, due to forgetfulness, or being too
busy or tired. For them, reminder messages acted as a
prompt to take their medications and reinforced the im-
portance of taking medications regularly. A female par-
ticipant who had been living with diabetes for 5 years
(oral medication and insulin), said the messages helped
her to become more self-reliant:
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“I no longer have this thing where you will find my
sugar high. It’s all thanks to the SMSes, they help
me. ‘Don’t forget your time’, … ‘Don’t forget your in-
jection time’, ‘Don’t forget time to take pills.’” (Fe-
male, SA, IDI)
Similarly, a female participant from Malawi, living with
diabetes for 5 years, explained that the messages helped
her to keep going with taking her medications despite
the side-effects, whereas before she would miss dosages
when she felt nauseas.
Even those with good adherence described having the
occasional slip-up. A participant described how a per-
fectly timed reminder message once prevented her skip-
ping her night-time dose:
“I see they encourage us a lot, like this other day I
was coming from my business, and I was very tired,
and I was just dreaming of getting home, taking a
bath and sleep. But before I slept, I just received the
text asking me if I have taken my medications. That
day I completely forgot; thanks to the message it
reminded me, otherwise I could have slept without
taking the medications.” (Female, MLW, FGD).
A few participants also appreciated the messages about
managing one’s medication in risky situations, such as
social gatherings and travelling. They made sure to al-
ways keep a spare dose of medicine when travelling or
attending social events.
Participants appreciated the importance of taking
medicines regularly and long-term, but in many cases,
despite their best efforts, their adherence behaviour fell
short. They described a range of partial adherence beliefs
and practice that had become part of their normal rou-
tine. The brief messaging did not seem to shift these be-
liefs and practices. Such behaviours included, for
example, skipping one or more of their dosages on a
regular basis, dropping one of their prescribed diabetes
medications, taking a break from taking their medicine
for a couple of days or even months, or substituting with
alternative remedies. The partial adherence behaviours
was reportedly in response to difficult and distressing
side effects of diabetes medicine that are ignored by cli-
nicians, and insufficient knowledge and counselling to
understand why changes are made to their treatment.
Other reasons include pill fatigue, beliefs about giving
the body “a break” or “cleaning” the body from time to
time, valuing alternative herbal remedies, concerns about
different chronic medications “clashing” with each other,
and suspicion of prescribed medicine with a different ap-
pearance. These beliefs and practices seem to be fairly
entrenched for some, and often operated in parallel
(even in contradiction) to their beliefs in the importance
of following doctor’s orders.
Healthy lifestyle messages provide knowledge and
motivation for healthy behaviour
Healthy eating Participants were generally aware of the
need to have a healthy diet, but reported a lack of ad-
equate, useful, and timely information to guide them.
They had concerns about what constitutes a healthy diet,
and what local foods were available and affordable for
people with diabetes. In addition to this knowledge def-
icit, participants had different levels of belief in the value
of health eating, alongside medication. Some participants
became more convinced over the years, while others be-
came less convinced about the importance of health eat-
ing. A woman with substantial weight loss due to
healthier eating (she dropped 3 dress sizes) became disil-
lusioned about healthy eating when her blood sugar level
did not stabilize. By contrast, a male participant who
had a dramatic improvement in his health became con-
vinced it was due to his running and weight loss. Mala-
wian participants who did home-farming felt it kept
them physically active and provided healthy produce for
their families.
Participants noted that messages about healthy eating
increased their awareness, made them conscious of what
they are eating, reinforced their own ongoing efforts,
and provided them encouragement and practical advice
on what foods to eat and to avoid. They recalled mes-
sages on limiting fat, oily and sugary foods, and about
using healthier food substitutes. A participant explained
how these messages helped her manage her diet:
“I remember that it is important to reduce fats and
reduce sugar. If for example, I crave red meat, I need
to ensure that I remove the fats, and to boil it in-
stead of frying, so to assist the medication I take. It
will be pointless for me to take pills and eat un-
healthy because it might look like the medication
does not work.” (Female, SA, IDI)
A male participant who was diagnosed with diabetes
the year prior to enrolling in the trial, said he was well-
informed about what foods to eat and to avoid, but that
the messages were useful as it helped him to better man-
age his cravings for the wrong foods. The messages also
helped with managing household challenges of cooking
and eating, such as getting family support for changing
to healthier food options. A woman living with diabetes
for 6 years, described how the messages helped to per-
suade her family to use healthier food preparation:
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“I was telling me children, please just boil my food,
they refuse. They say I am just being stubborn. So,
when I received a message from StAR2D talking
about fried foods, I showed them and now they are
still applying this knowledge whenever they are cook-
ing, and they cook without adding oil”. (Female,
MLW, FGD)
Adhering to healthy eating at social events can be
challenging and for a couple of participants, the mes-
sages helped to remind them to eat in moderation at so-
cial events.
Physical activity Participants noted that although they
were aware of the importance of regular exercise, they
felt exercise was hard to achieve. They appreciated the
messages for suggesting more feasible ways of keeping
physical active. The exercise related messages motivated
a few participants to increase their physical activity by
walking more, doing more housework and gardening,
and even considering dancing for exercise:
“Yes, I started doing exercises instead of just staying
[inactive]. And they even told us if you cannot man-
age to do exercises, you can put music on your phone
or switch on the radio and start dancing.” (Female,
MLW, IDI)
Stress management Some participants were convinced
that stress was the reason for their high and fluctuating
blood sugar levels, and some found the stress manage-
ment messages particularly helpful. They felt stressed
when their efforts to be adherent to treatment (taking
medicine and healthy eating), did not lead to improve-
ment in their blood sugar levels. Other stressors in-
cluded loss of a spouse or other family members, and
chronic worries about a range of issues (for example, on-
going ill health, one’s diet, substance abuse in the family,
financial insecurity, visiting an overcrowded clinic and
being scolded by clinic staff). The messages reminded
and prompted them to make a conscious effort to better
manage their stress. For example, avoiding getting
stressed by other people’s problems, keeping busy as way
of managing stress (one women helped in the family
home shop), and reminding themselves to relax when
their sugar level was high.
Complex factors influencing diabetes adherence and
engagement with the intervention
As mentioned earlier, participants reported a range of
partial adherence behaviours that seem to be routine
and influenced by individual beliefs as well as social fac-
tors and health service challenges. Partial adherence
behaviour included reducing and skipping medication,
taking alternative medicine, and struggles with eating a
healthy diet, exercising, and managing their stress. Below
we detail some of the underlying reasons.
Diabetes distress
The overall impression, from some participants, was that
living with diabetes was difficult and distressing, more so
than the other chronic diseases they suffered from (like
hypertension, high cholesterol). The main reasons for
the distress relate to the seriousness and discomfort of
the symptoms, the fluctuations in blood sugar levels, un-
predictability of health changes, and a chronic sense of
not being able to control the disease, no matter their ef-
forts. Living with co-morbid diseases further compli-
cated the experience. Dealing with fluctuations of
symptoms from multiple diseases was frustrating, as was
the different intervals required for taking diabetes medi-
cation (compared to medicine intervals for their other
chronic diseases).
Navigating complex and contested interactions with health
services
Participants had an appreciation for efforts by the health
services but found patient-provider relationships to need
improvement. They felt their views were not sufficiently
considered, that complaints of side effect were ignored,
there was insufficient clinical communication about
treatment, lack of affirmation of patient efforts, and in
places, poor organisation of patient care and limited ac-
cess to medicines – factors that contributed to stress
and demotivation with managing their diabetes
treatment.
What helps to manage diabetes?
Accepting one’s diagnosis and coming to terms with the
need for lifelong medicine was a key factor in improving
managing of diabetes. Acceptance meant worrying less
about the underlying reasons for one’s condition, feeling
empowered to take more self-responsibility for one’s
treatment and health, and finding it easier to follow
medical advice about adherence. A female participant
living with diabetes for over a decade learnt from a ‘role-
model’ diabetes patient in the community, who helped
her to be more accepting of the illness, and to “… just
abide what we are told at the hospital” (Female, MLW,
IDI). Other sources of support came from family,
friends, religious faith, ‘good diabetes’ patient role
models, regular health awareness talks (mainly in
Malawi), and counselling and affirmation from health
care staff.
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Discussion
This process evaluation examined the experiences and
perceptions of participants in randomised controlled
study that tested the effect of brief text messaging sup-
port for adherence to diabetes treatment. It found that
the messages were considered acceptable and useful, and
improved their adherence behaviour for some. However,
against a background of complex coping challenges, and
the routine practice of partial adherence behaviours,
their ability to act on the messages was limited. This
context may explain in part, why the intervention did
not have a positive impact on glycemic control. Process
evaluations alongside trials are valuable for generating
insights about the potential underlying causal mecha-
nisms of the intervention and can inform development
of other programmes [33].
Similarities between Malawi and south African responses
Despite the differences in the way people live and access
health services in Malawi and South Africa, the experi-
ence and perceptions of the text-message intervention
was similar across sites. Malawi patients were a mix of
urban and rural, had longer commutes, with 3 monthly
visits, breaks in continuity of access to free diabetes
medicine, and seemed to enjoy a more positive and
trusting relationship with the health services. The South
African patients were urban, living near the health facil-
ity, with monthly or 2 monthly visits, continuous access
to free diabetes medications, but with more negative
perception and less trust in the health service.
Similar complexities of living with diabetes emerged in
both sites in the StAR2D intervention development
study [45], as well as in other studies [11, 13, 14, 51, 52].
It may be that the complex influences that limit diabetes
adherence, would also limit the impact of text messaging
on adherence behaviour outcomes.
Engagement and relational responses
In this study, those who expressed a benefit, indicated
the reminder messages helped to prompt the desired be-
haviour (mainly in terms of jogging their memory),
which speaks to the behaviour change domain of en-
hanced psychological ‘Capability’ in the COM-B frame-
work. The reminders also reinforced their beliefs about
the need for treatment and increased their sense of sup-
port and self-efficacy. This had the reported effect of
motivating them to be more self-reliant and improve
their adherence behavior, which speaks to the ‘Motiv-
ation’ domain of COM-B framework. Nevertheless, for
the most part, the messages did not seem to change
their beliefs and practices around partial adherence, for
example, taking treatment breaks and use of alternative
remedies. There was also limits to the ‘Opportunity’ do-
main, as the messages did not make a difference to the
physical or social challenges shaping adherence behav-
iour, such as the complexity of the medical regime, and
challenges around accessibility and experience of health-
care services. The barriers to the Motivation and Oppor-
tunity domains of the COM-B framework may in part
explain the limited adherence behaviour change ob-
served in the trial outcomes.
Studies have found that while text messaging often has
wide acceptability, with positive effects in some areas,
like smoking cessation and antiretroviral medication ad-
herence [17], the evidence for diabetes is mixed [20, 21,
24, 25, 53, 54]. In a study showing long-term success for
diabetes management, the intervention was multi-modal;
tailored and interactive text messaging, self-monitoring
relating to use of insulin, and ability to contact a health
care provider [22, 23, 55].
A cross-cutting issue is the relational aspect of the
mHealth intervention, which had two elements. Firstly,
participants in both settings appear to value not only the
content of the text messages, but also the sense of sup-
port and encouragement they got from merely receiving
messages; almost as if they had established a virtual car-
ing relationship with the sender of the message. Sec-
ondly, they also experienced a sense of support and
encouragement from participating in the research study,
whether they were receiving the intervention or not.
This came from positive interactions with research staff
at the beginning and end of the study. These relational
effects were more pronounced for South African partici-
pants; perhaps as it contrasted more starkly with their
negative perceptions of the health services. A similar re-
lational effect of digital messaging was found in the Cape
Town hypertension adherence study [12], in Kenya with
anti-retroviral adherence [56] and in a high income
country setting, with cardiovascular adherence support
[57].
The complexities of adherence to diabetes treatment
The study highlighted a range of complex issues that
interact with and contribute to routine practice of partial
adherence behaviours (for medical and lifestyle adher-
ence). Participant responses shared a sense of lack of
control over, and limited capacity for improving their
diabetes-related health. The challenges relate to know-
ledge gaps on how to turn information into action, gaps
in continuous access to medicine, complexity of the
medical regime, healthcare interactions that are demo-
tivating, instability in symptoms of diabetes, debilitating
side effects that are not addressed, and beliefs and prac-
tices that negatively shape their adherence behaviour.
Living with other co-morbid disease further complicated
their efforts to manage their treatment regimens and to
maintain good health. Individual, social and health ser-
vice complexities such as those found in this study, has
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also been reported across settings and patient groups,
prompting calls for more innovative, multi-dimensional,
and tailored adherence interventions [11, 15, 25, 51, 58–
60].
It may be difficult for a text message by itself, to be ef-
fective in improving adherence behaviour and clinical
outcomes, against a background of an overburdened
health system, and where partial adherence beliefs and
practices are entrenched. While participants acknowl-
edged support efforts by health services, they experi-
enced health care as not sufficiently responsive to their
informational, clinical and support needs. A systematic
review of trials in other African settings, using one-way
brief text messaging confirmed the uncertain clinical ef-
fects; with no clear evidence of SMSes improving dia-
betes and hypertension management [53].
We used automated unidirectional SMSes to improve
the feasibility and scalability of the intervention, but lack
of direct, personalised communication with health care
workers may have contributed to the limited interven-
tion impact. A global review of tailored text messaging
for improving diabetes management reported moderate
improvements on blood glucose levels, but mostly in
high-income countries [60]. The review suggested that
certain aspects of tailoring messages may work better,
such as non-automated, direct, and personalised com-
munication. For example, where messages are sent from
a real health care worker, and when SMS communica-
tion is combined with other assessment tools. The direc-
tionality (unidirectional versus bidirectional automated
messaging) did not directly impact the effectiveness of
the interventions [20, 60].
Implication of the findings for research and practice
In the COM-B behaviour change model, all three of the
components of capability, motivation, and opportunity,
are needed for positive behaviour change to occur [46,
47]. Text messaging seem to address the capability and
motivation components, as evidenced by reports of feel-
ing encouraged and motivated, though messages could
not change social and physical opportunity barriers to
adherence. Complex, multi-dimensional interventions
may need to go beyond informational and motivational
support, to address the interactions of patient belief sys-
tems and practices and to improve trust and collabor-
ation between providers and patients [25, 48, 59].
Testing of complex interventions would need to be bal-
anced with the feasibility of implementing such interven-
tions at scale.
Strengths and limitations of the study
The process evaluation was part of a comprehensive
evaluation which included evidence- and theory-
informed intervention development and a costing study,
alongside a pragmatic randomised trial [39]. The longi-
tudinal perspective (interviewing the same individuals
pre- and post-trial) provided useful contextual informa-
tion and enriched our understanding of participant’s ex-
periences and views over time. Triangulating the use of
individual interviews and focus groups helped to
strengthen the credibility and reliability of the findings
and the sample had good representation from both gen-
ders. We think the study was strengthened by use of
mother-tongue interviewers that allowed for better un-
derstanding of cultural nuances, and where this was not
feasible, we used translation support. The lead re-
searchers of the qualitative study (NL1 and HM) were
also co-investigators on the main StAR2D trial, and we
ensured that there was an appropriate level of independ-
ence between the qualitative and quantitative research
team. We planned to interview a greater ratio of individ-
ual participants in the intervention compared to control
group, but this was a challenge due to logistics of keep-
ing allocation status confidential during the trial. We
would have liked to arrive at a more in-depth analysis of
how the COM-B behaviour change strategies operated,
but we think this requires a combination of methodolo-
gies including use of traditional qualitative approaches,
together with more focused, innovative qualitative tech-
niques, such as cognitive interviewing (used for market
research), and perhaps patient diaries. Combining this
with quantitative data on implementation processes out-
comes (coverage, fidelity), on quality of the health ser-
vices, and stakeholder views, may provide more
comprehensive insights to explain the impact of experi-
mental studies [31, 36, 46].
Conclusion
This process evaluation study provided context and
insight into the factors influencing participants’ re-
sponses to the text messaging intervention in a trial
aimed at improving diabetes clinical outcomes and ad-
herence behaviours. While participants found brief text
messaging acceptable and useful, the complexity of the
context in which patients take their diabetes medication,
may explain in part, why brief text messaging was insuf-
ficient to improve clinical and behaviour impact of the
trial. The scale of need for self-management and health
service support suggests that digital approaches alone
may be unsuccessful, unless accompanied by health sys-
tem strengthening and other forms of self-management
support.
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